Fri, October 30, 2020
Thu, October 29, 2020
Wed, October 28, 2020
Tue, October 27, 2020
Mon, October 26, 2020
Fri, October 23, 2020
Thu, October 22, 2020

David Nierengarten Upgraded (ANAB) to Buy and Increased Target to $35 on, Oct 27th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-35-on-oct-27th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Nierengarten of Wedbush, Upgraded "AnaptysBio, Inc." (ANAB) to Buy and Increased Target from $20 to $35 on, Oct 27th, 2020.

David has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $36 on, Wednesday, October 14th, 2020

Publication Contributing Sources